Decibel Cannabis Company Inc. (TSXV: DB)(OTCQB: DBCCF), a prominent player in premium cannabis and extract products has taken a significant stride in its global expansion strategy.

UK Partnership: A Gateway To European Expansion

The Canadian company has inked a supply agreement with 4C LABS, a leading UK-based healthcare, technology and pharmaceutical firm specializing in cannabis-based medicinal products. This move solidifies Decibel's foothold in the UK market.

Adam Coates, CRO at Decibel, expressed enthusiasm for the collaboration, noting its potential to …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.